Estimation of oxidative stress in patients with Parkinson's disease
10.3760/cma.j.issn.1671-8925.2009.01.016
- VernacularTitle:帕金森病患者体内氧化压力的定量分析
- Author:
Wei-Ping GUAN
1
;
Pei-Gen KUANG
;
Sheng-Yuan YU
;
Wei-Ping WU
;
Hirofumi METOKI
Author Information
1. 解放军总医院
- Keywords:
Parkinson's disease;
Oxidative stress;
Low-density lipoprotein
- From:
Chinese Journal of Neuromedicine
2009;8(1):54-56
- CountryChina
- Language:Chinese
-
Abstract:
Objective To measure the changes in urinary 8-iso-prostaglandin-F2α (8-iso-PGF2α) and oxidized low-density lipoprotein (ox-LDL) lag time in patients with Parkinson's disease (PD). Methods A case-control study was performed involving 31 male patients with PD (mean age of 59.7 years) diagnosed according to the Calne criteria and 31 age-matched healthy male subjects with comparable status of smoking and life style. For each subject, urinary 8-iso-PGF2α was measured quantitatively using enzyme-linked immunosorbent assay, and LDL oxidizability was measured by determining LDL oxidation lag time in conjugated diene product at 234 nm using Cu-stimulated oxidation. Results Compared to the levels in the control subjects, the PD patients showed significantly increased urinary 8-iso-PGF2α (81.1±1.6 vs 46.9±1.1 ng/mmol creatinine, P<0.05) and significantly reduced LDL oxidation lag time (63.5±6.0 vs 84.4±8.8 min, P<0.05). Conclusion Increased 8-iso-PGF2α and decreased anti-oxidant ability are implicated in the pathogenesis of PD, suggesting the value of appropriate antioxidant therapy in controlling the progression of PD.